UNSPSC 51313701: Quinotolast

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H12N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SUC3551A8U, chemically known as 4h-quinolizine-3-carboxamide, 4-oxo-1-phenoxy-n-1h-tetrazol-5-yl but generally known as quinotolast, which bears US NIH Compound Identifier 65871. European Medicines Agency schedules Quinotolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10220MIG.

UNSPSC 51313701 Quinotolast is a Commodity code, but the recent state and local opportunity record tagged under it does not reflect pharmaceutical products or pharmaceutical-adjacent goods—instead, it documents a Seminole County, Florida procurement for naloxone and drug deactivation systems, which fall outside the nominal scope of this code. The mismatch suggests the opportunity was miscoded or the tagging reflects a downstream health-agency classification rather than the UNSPSC standard. State and local procurement activity under this Commodity code shows little relevant recent posting history, and a single opportunity record fails to establish meaningful scope, issuing-body patterns, or geographic concentration sufficient to characterize current market demand.

Without additional opportunities properly tagged to this code across state and local jurisdictions, no reliable profile of active buying patterns, repeat purchasers, or geographic hotspots can be drawn. Business development professionals evaluating this code should treat the current activity as inactive or verify the code's proper application with issuing bodies before investing pursuit resources.